ARTICLE | Company News
Gilead completes Pharmasset deal
January 18, 2012 1:55 AM UTC
Gilead Sciences Inc. (NASDAQ:GILD) completed its acquisition of HCV company Pharmasset Inc. for $137 per share in cash, or about $11.2 billion (see BioCentury, Dec. 5, 2011). ...